Ojas Doshi
Making Treatment Advancements
Doshi demonstrates a can-do mentality, focusing on the creation of therapeutic regimens capable of meeting a patient’s needs rather than forcing you to adapt to tired, antiquated methods. He addresses existing problems and seeks immediate solutions regarding patient care and how healthcare companies should approach these matters. As aging persons encounter growing rates of various eye-related maladies, the need to make strides regarding drug delivery carries greater urgency. It is a life-long goal that Doshi intends to attain.Displaying Notable Foresight
Doshi takes pharmaceutical science to another level. He emphasizes that drug delivery methods go beyond formulations and must also consider other key topics, including the importance of treating patients like people rather than merely test subjects and making sure that they get the most out of their treatment with the least amount of difficulty. As the product development scientist at Cosette Pharmaceuticals, Inc., he applies his knowledge of new drug applications (NDA) and abbreviated new drug applications (ANDA) to therapeutics such as topical creams, oral preparations, and sterile dosage forms. His most noteworthy contributions are in eye care-related drug delivery and oral solutions. His undying attention to improved patient care outcomes has led to Doshi creating variations of eye infection-combating drugs like tobramycin and moxifloxacin. Such preparations strengthen each drug’s potency, are simpler to administer, and do not need to be taken as often. They have also improved patient adherence by shortening recovery times and lessening associated medical costs. “Innovation is bridging the gap between pharmaceutical discovery and practical, patient-friendly solutions,” Doshi said.
Ojas Doshi
